Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors

Journal Article · · J. Med. Chem.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; INDUSTRY
OSTI ID:
1900949
Journal Information:
J. Med. Chem., Vol. 65, Issue (17)
Country of Publication:
United States
Language:
ENGLISH

References (28)

Mechanisms of Autophagy Initiation journal June 2017
Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function journal January 2012
Vps34 regulates Rab7 and late endocytic trafficking through recruitment of the GTPase activating protein Armus journal January 2016
Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells journal March 2013
Tissue-based map of the human proteome journal January 2015
Vps34 PI 3-kinase inactivation enhances insulin sensitivity through reprogramming of mitochondrial metabolism journal November 2017
Functional genomic landscape of cancer-intrinsic evasion of killing by T cells journal September 2020
Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner journal October 2017
Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy journal May 2020
Autophagy protects tumors from T cell–mediated cytotoxicity via inhibition of TNFα-induced apoptosis journal December 2020
Autophagy, the innate immune response and cancer journal August 2020
Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles journal May 2017
Discovery of (2 S )-8-[(3 R )-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2 H -pyrimido[1,2- a ]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors journal July 2014
Potent, Selective, and Orally Bioavailable Inhibitors of VPS34 Provide Chemical Tools to Modulate Autophagy in Vivo journal November 2015
Targeting autophagy by small molecule inhibitors of vacuolar protein sorting 34 (Vps34) improves the sensitivity of breast cancer cells to Sunitinib journal October 2018
Autophagy-monitoring and autophagy-deficient mice journal September 2017
Optimization of Orally Bioavailable PI3Kδ Inhibitors and Identification of Vps34 as a Key Selectivity Target journal December 2019
The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326) journal January 2016
Phosphatidylinositol(3)-Phosphate Signaling Mediated by Specific Binding to RING FYVE Domains journal July 1998
Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo journal October 2014
Structural insights into phosphoinositide 3-kinase catalysis and signalling journal November 1999
Phosphatidylinositol 3-Kinase (PI3K) and Phosphatidylinositol 3-Kinase-Related Kinase (PIKK) Inhibitors: Importance of the Morpholine Ring journal July 2014
A Novel Method for High Throughput Lipophilicity Determination by Microscale Shake Flask and Liquid Chromatography Tandem Mass Spectrometry journal November 2013
XDS journal January 2010
Overview of the CCP 4 suite and current developments journal March 2011
Phaser crystallographic software journal July 2007
Features and development of Coot journal March 2010
Towards automated crystallographic structure refinement with phenix.refine journal March 2012